Johnson & Johnson plans to separate the Company’s Consumer Health business, creating a new publicly traded company. The planned separation would create two global leaders and allow for greater innovation and flexibility to pursue more targeted business strategies and accelerate growth.   The new Johnson & Johnson would remain a diverse healthcare company and continue its commitment to R&D and innovation, with a portfolio that blends its Pharmaceutical and Medical Device capabilitie...